Whether you choose GLP-1 medication, natural alternatives, or a combination approach, the key is comprehensive support
Recent analyses of adverse event reporting systems have found disproportionate reporting of dizziness and balance disorders with GLP-1RAs compared to other antidiabetic medications [46]
Xue X, Ren Z, Zhang A, et al
doi:10.1016/j.molmet.2020.101102 34
Arrhythmic Gut Microbiome Signatures Predict Risk of Type 2 Diabetes
"We believe that pemvidutide, if approved, could stand out as an attractive option for weight loss and weight maintenance." Other drugmakers are trying to solve the issue of patients losing muscle while on drugs like Ozempic In July, Eli Lilly, which makes Zepbound and Mounjaro, acquired Versanis, a privately held, clinical-stage biopharmaceutical company